Dr. Richard Moakes retweeted
⏰ Set your reminders! Graeme, Isla and Andy Grist will be on the @BBCBreakfast couch at 8:10am tomorrow (22nd May).
Please watch Graeme & Isla's video to see the challenges that people living with EB, like Isla, face in their day-to-day life. 🦋
#BBCBreakfast #GraemeSouness
Dr. Richard Moakes retweeted
Check out our paper on Engineered Extracellular Vesicles: Tailored-Made Nanomaterials for Medical Applications which is in the running for the Nanomaterials 2022 Best Paper Award.
Read the full paper here: pubmed.ncbi.nlm.nih.gov/3294…
@KennyMan888 @MathieuBrunet_ @sophieccox
Dr. Richard Moakes retweeted
🦋 Does EB only affect the skin? 🦋 EB is certainly more than just skin deep. The physical symptoms can also manifest internally as well as have a profound effect on a person's well-being #EBAwarenessWeek
Dr. Richard Moakes retweeted
Congratulations to our amazing @CDTLifETIME PhD student, @HannahCLamont on her first publication! In this paper we discuss 3D modelling of the eye’s trabecular meshwork for #glaucoma research. @HTIbham @unibham_SoBMS
unavailable
Dr. Richard Moakes retweeted
A flow device allows control of the height and in situ purification of chemical gardens, which can be encased in a photoset hydrogel for subsequent applications @erikhughes20 @_TomERobinson @RichardMoakes @MirunaChipara @DWLiam @HTIbham go.nature.com/3joCWL5
Dr. Richard Moakes retweeted
In this paper, Erik Hughes shows how it is possible to precisely control the growth of calcium phosphate tubes from a surface. Lots of possibilities for how they can be used. Nice one Erik 👏👏
A flow device allows control of the height and in situ purification of chemical gardens, which can be encased in a photoset hydrogel for subsequent applications @erikhughes20 @_TomERobinson @RichardMoakes @MirunaChipara @DWLiam @HTIbham go.nature.com/3joCWL5
Dr. Richard Moakes retweeted
Last chance to register to the COST Action #Chemobrionics meeting in Ankara 22-24 Sept 2021. No conference fees, free acces to all registered participants. Two options of attendance: Either virtualy, or in-person (we can cover you the travel expenses). Join us!
@COSTprogramme
COST Action #Chemobrionics annual meeting 2021 is going to be a hybrid event this year.
Online & In-person part in Ankara (Turkey)
22.-24.09.2021
REGISTRATION OPEN
chemobrionics.eu/events-1/co…
Free attendance
Travel grants for @COSTprogramme partners
Dr. Richard Moakes retweeted
Interfaces are important in biofabrication. That’s how different material phases (and cells) interact with each other in bioprinted structures. Check out recent review on this topic. Congrats @Martina52072149 for the great work. @RMUtrecht @UUPharmaceutics @TUeindhoven @Uni_WUE
Latest review from the group: The Importance of Interfaces in Multi‐Material Biofabricated Tissue Structures onlinelibrary.wiley.com/doi/…
@TVermonden @Martina52072149 @RMUtrecht @MiguCastilho @juergengroll
Dr. Richard Moakes retweeted
The custom microfluidic devices reported in this paper simulate microgravity, allowing crack-free growth of 2D porous crystalline molecular frameworks
@PaneSalvador @PuigmartiLuis
Read the article: ow.ly/pDSt50FGRsE
Dr. Richard Moakes retweeted
Blurring the boundaries between 🎨 and 🔬 check out this selection of stunning 🤩 images published in the last month: ow.ly/li9B50FwrCs
Dr. Richard Moakes retweeted
Biomechanics is one of the major challenges in biofabrication of implantable tissues. Join me at the #Biomaterials 2.30-3.30 session today at @ESBiomech_2021 where I’ll discuss some recent strategies to tackle this. At the crossroad of two research societies @ISBioFab @ESBiomech
Dr. Richard Moakes retweeted
In this new review we explain fundamental rheology principles for bioinks and suspension media for bioprinting. We describe rheological analyses that can be carried out to characterise these materials and highlight some recent work in the field. Enjoy! aip.scitation.org/doi/10.106…
Dr. Richard Moakes retweeted
Pleased to see our latest paper published @Nature_NPJ rdcu.be/cddbM. We demonstrated that a newly formulated LMW-dextran sulfate (ILB®) resolved inflammation in human cell disease models and reduced trabecular meshwork matrix deposition in a rat model of #glaucoma
Dr. Richard Moakes retweeted
Anti-#COVID19 nasal spray ‘ready for use in humans’ and could inhibit the infection for up to 48 hours, say an @HTIbham team based in the ITM >
itmbirmingham.co.uk/anti-cov… @RichardMoakes @DWLiam
Dr. Richard Moakes retweeted
This video is well worth a watch. EB is a terrible condition and anything that we can do to help deliver technologies to prevent the worst of these symptoms will be worth it. Charitable contributions to @CharityDEBRA help drive forwards work like this.
📰| A new spray for treating severely painful blisters, mouth ulceration and oral scarring in patients with #EpidermolysisBullosa (EB) is being developed by @HTIbham
and @InflamAge_UoB researchers and funded by @CharityDEBRA
birmingham.ac.uk/news/latest… @eps_unibham
Dr. Richard Moakes retweeted
Fifty people online for the @HTIbham seminar by Nan Gao @eps_unibham about superhydrophobic surfaces. Calling anyone else across @unibirmingham and beyond who wants to give talk in our Institute Seminar...DM me.
Dr. Richard Moakes retweeted
We started the PPIE process with this project yesterday so that we can design something with the best chance of working for the patients and their carers. Incredibly proud to be working towards a useful and hopefully life-changing product for these patients!
.@HTIbham has partnered with @CharityDEBRA to #FightEB - our researchers will use their expertise in anti-scarring technologies to develop an oral spray which will ease the pain patients experience when they eat and brush their teeth > birminghamhealthpartners.co.… #EBAwarenessWeek

ALT Caroline Collins, Director of Research at DEBRA says: “The development of this spray could be a giant step forward in helping to alleviate the constant pain and discomfort EB sufferers experience on a daily basis. The combination of delivery and use of treatments that reduce fibrosis could mean an EB patient is able to properly eat for the first time and maintain basic dental hygiene which many of us take for granted. I am hugely grateful to the team in Birmingham for making this happen.”
Dr. Richard Moakes retweeted
Our new article is now online! Great work by @megscooke @hyereepark @joseramirez @karlarangel-berridi frontiersin.org/articles/10.…
Dr. Richard Moakes retweeted
Paper ➡️ poutine. frontiersin.org/articles/10.… – at Montréal, Québec
Dr. Richard Moakes retweeted
Want to additively manufacture implant surfaces that allow for cell attachment while minimising bacterial adhesion? With support from @EPSRC and @RenishawMedical we’ve created a design tool to do just that: authors.elsevier.com/c/1bbi1… – at Coventry, England



























